![Aleksandrs Zhavoronkov](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aleksandrs Zhavoronkov
Gründer bei InSilico Medicine Hong Kong Ltd.
Ursprung des Netzwerks ersten Grades von Aleksandrs Zhavoronkov
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Insilico Medicine Cayman TopCo
![]() Insilico Medicine Cayman TopCo Miscellaneous Commercial ServicesCommercial Services InSilico Medicine Cayman TopCo is a holding company, which engages in the research and development of generative artificial intelligence (AI) driven therapeutic pipeline and software licensing. Its pipeline targets areas include high unmet needs, with a footprint in fibrosis, oncology, immunology, and other therapeutic areas. The company was founded by Alex Zhavoronkov on November 19, 2018 and is headquartered in Hong Kong.
15
| Subsidiary | Miscellaneous Commercial Services | 15 |
LongeVC
![]() LongeVC Investment ManagersFinance LongeVC is a venture capital firm, founded in 2020 by Garri Zmudze, Ilya Suharenko, Sergey Jakimov. The firm is headquartered in Lugano, Switzerland.
15
| Private Company | Investment Managers | 15 |
InSilico Medicine, Inc.
![]() InSilico Medicine, Inc. Packaged SoftwareTechnology Services Part of InSilico Medicine Hong Kong Ltd., InSilico Medicine, Inc. is a clinical stage biotechnology company based in New York, NY. InSilico Medicine is focused on generative models, reinforcement learning, and other modern machine learning techniques for the generation of new molecular structures with specified parameters, generation of synthetic biological data, target identification, and prediction of clinical trials outcomes. The company has developed AI platforms that utilize deep generative models, reinforcement learning, transformers, and other modern machine learning techniques for novel target discovery and the generation of novel molecular structures with desired properties. InSilico Medicine is developing breakthrough solutions to discover and develop innovative drugs for cancer, fibrosis, immunity, central nervous system diseases, infectious diseases, autoimmune diseases, and aging-related diseases. The company was founded in 2014 by Aleksandr Aliper and Aleksandrs Zhavoronkov. Aleksandrs Zhavoronkov has been the CEO since 2014.
9
| Subsidiary | Packaged Software | 9 |
Alliance For Artificial Intelligence In Healthcare
![]() Alliance For Artificial Intelligence In Healthcare Packaged SoftwareTechnology Services The Alliance for Artificial Intelligence in Healthcare (AAIH) is an advocacy organization that aims to improve patient outcomes and minimize healthcare costs through the discovery, development, and delivery of better solutions. The private company is based in Long Island City, NY, and was founded by Brandon Allgood. The organization fosters creativity, collaboration, and knowledge sharing among its members, who come from diverse backgrounds in science, math, technology, and healthcare. AAIH is focusing on two primary practice areas in 2023: developing a comprehensive framework for digitizing IND and addressing core challenges in data accessibility through a real-world data registry.
6
| Private Company | Packaged Software | 6 |
InSilico Medicine Hong Kong Ltd.
![]() InSilico Medicine Hong Kong Ltd. Information Technology ServicesTechnology Services InSilico Medicine Hong Kong Ltd. operates as bioinformatics company, which utilizes advances in genomics, big data analysis and deep learning for silico drug discovery and drug repurposing for aging and age-related diseases. The company was founded by Alex Zhavoronkov and is headquartered in Hong Kong.
4
| Holding Company | Information Technology Services | 4 |
Deep Longevity Ltd.
![]() Deep Longevity Ltd. Packaged SoftwareTechnology Services Deep Longevity Ltd. develops artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system and psychological levels. Its products include longevity cloud, recommendation engines, deep aging clocks and age metric reports. The company was founded in 2020 by Alex Zhavoronkov and is headquartered in San Diego, CA.
3
| Subsidiary | Packaged Software | 3 |
Biogerontology Research Foundation
1
| Private Company | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Aleksandrs Zhavoronkov
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Fudan University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Stanford University | College/University | Masters Business Admin Masters Business Admin Doctorate Degree | |
Longenesis SIA
![]() Longenesis SIA Data Processing ServicesTechnology Services SIA Longenesis promotes collaboration between biomedical institutions, patient organizations, and research partners. The company is based in Riga, Latvia and has subsidiaries in Hong Kong. The Latvian company identifies biomedical data from metadata files, onboards population cohorts, and engages new patients in research. The company was founded by Garri Zmudze. | Data Processing Services | Director/Board Member Founder | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Doctorate Degree | |
HYGEIA HEALTHCARE HOLDINGS CO., LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
King's College London | College/University | Undergraduate Degree Undergraduate Degree | |
HTDK Medical Holdings Ltd.
![]() HTDK Medical Holdings Ltd. Financial ConglomeratesFinance HTDK Medical Holdings Ltd. operates as an investment holding company. It is principally engaged in providing product commercial solutions in medical device and consumer healthcare product sectors. The company specializes in medical device enterprises which cover the diagnosis, orthopedics, ophthalmology, cardiovascular and other indications. The company was founded on July 9, 2021 and is headquartered on Shanghai, China. | Financial Conglomerates | Chairman Corporate Secretary | |
University of Pennsylvania | College/University | Undergraduate Degree Doctorate Degree | |
Kira Pharmaceuticals LLC | Director/Board Member | ||
Suzhou Connect Biopharma Co. Ltd.
![]() Suzhou Connect Biopharma Co. Ltd. Pharmaceuticals: MajorHealth Technology Suzhou Connect Biopharma Co. Ltd. develops novel medicines for the treatment of autoimmune diseases and inflammation. Its products include CBP-307, CBP-174, and CBP-201. The company was founded by Zheng Wei and William Pan in 2012 and is headquartered in Taicang, China. | Pharmaceuticals: Major | Director/Board Member | |
Case Western Reserve University
![]() Case Western Reserve University Other Consumer ServicesConsumer Services Case Western Reserve University provides educational services. It offers a variety of undergraduate degree courses and graduate and professional options such as arts and sciences, dentistry, engineering, law, management, medicine, nursing, social work, and more. The firm also offers dual-degree programs. The company was founded in 1826 and is headquartered in Cleveland, OH. | College/University | Doctorate Degree | |
Antengene Corporation Co., Ltd.
![]() Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
ABBISKO CAYMAN LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Compass Asset Management SA
![]() Compass Asset Management SA Investment ManagersFinance Compass Asset Management SA is a private asset management firm based in Lugano, Switzerland. Founded in 1998, their clients are both private and institutional investors. They manage a number of Luxembourg-domiciled funds. | Investment Managers | Consultant / Advisor | |
The Cointelegraph | Consultant / Advisor | ||
Iotex
![]() Iotex Data Processing ServicesTechnology Services Iotex engages in the provision of auto-scalable and privacy-centric blockchain platform for the Internet of Things. Its development includes a root chain/subchains architecture for heterogeneous computing, Roll-DPoS consensus mechanism for high scalability, and lightweight privacy-preserving techniques, The company was founded by Raullen Chai, Qevan Guo, andJing Sun in 2017 and is headquartered in Menlo Park, CA. | Data Processing Services | Consultant / Advisor | |
PsyMed Ventures Management LLC
![]() PsyMed Ventures Management LLC Investment ManagersFinance PsyMed Ventures Management LLC (PsyMed Ventures) is a venture capital firm founded in 2020 by Dina Burkitbayeva and Matias Serebinsky. The firm is headquartered in Tahoma, California. | Investment Managers | Private Equity Investor | |
ANTENGENE CORPORATION LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Sheba Medical Center
![]() Sheba Medical Center Hospital/Nursing ManagementHealth Services Sheba Medical Center is a hospital engaging in medical science and biotechnical innovation. Its services include emergency room services, cancer treatment, psychiatry, and hematological examination. The company was founded on June 21, 1948 and is headquartered in Ramat Gan, Israel. | Hospital/Nursing Management | Director/Board Member | |
Sintetica SA
![]() Sintetica SA Pharmaceuticals: MajorHealth Technology Sintetica SA operates as a pharmaceutical company that provides injectable anaesthetics and analgesics. The company was founded in 1921 and is headquartered in Mendrisio, Swizerland. | Pharmaceuticals: Major | Chief Executive Officer | |
Tethis SpA
![]() Tethis SpA BiotechnologyHealth Technology Tethis SpA engages in the provision of nanobiotechnology solutions. It develops devices for liquid biopsy, molecular diagnostic, and proteomic and microbiology. The company was founded by Emanuele Barborini, Simone Vinati, and Massimo Gatelli in 2004 and is headquartered in Milan Italy. | Biotechnology | Director/Board Member | |
Qiming Venture Partners Ltd.
![]() Qiming Venture Partners Ltd. Investment ManagersFinance Qiming Venture Partners Ltd (Qiming Venture Partners) is a venture capital subsidiary of Qiming Caymen Ltd founded in 2006 by Gary Rieschel, Zi Ping Kuang and Ignition Partners LLC. The firm is headquartered in Shanghai, China. | Investment Managers | Private Equity Investor | |
CANbridge Life Sciences Ltd.
![]() CANbridge Life Sciences Ltd. Pharmaceuticals: MajorHealth Technology CANbridge Life Sciences Ltd. produces biopharmaceutical products. It engages in the research and development of therapeutic drug treatment for critical medical condition. The company was founded by James Xue on June 12, 2012 and is headquartered in Chaoyang, China. | Pharmaceuticals: Major | Director/Board Member | |
Nerviano Medical Sciences SRL
![]() Nerviano Medical Sciences SRL Pharmaceuticals: MajorHealth Technology Nerviano Medical Sciences SRL provides pharmaceutical services. The company is headquartered in Nerviano, Italy. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Fusix Biotech GmbH
![]() Fusix Biotech GmbH BiotechnologyHealth Technology Fusix Biotech GmbH is a private company located in Germany that aims to deliver breakthrough cancer immunotherapies utilizing a unique "fusogenic" mechanism of action to directly kill tumor cells, heat up the tumor microenvironment, and mediate systemic immune effects to target tumor cells throughout the body. The German company is still part of the Klinikum rechts der Isar of the Technical University Munich and is currently planning to spin-out in 2022. The Fusix technology offers a unique mechanism of action that will revolutionize immune oncology in solid cancers by converting the tumor microenvironment from an immune suppressed “cold” tumor into an immune-sensitized “hot” tumor infiltrated with immunotherapeutics. | Biotechnology | Corporate Officer/Principal | |
QEEKA HOME (CAYMAN) INC. | Internet Software/Services | Corporate Secretary | |
JIAYUAN SERVICES HOLDINGS LIMITED | Real Estate Development | Investor Relations Contact | |
SHANGHAI ELECTRIC GROUP COMPANY LIMITED | Electrical Products | Corporate Secretary | |
The Hong Kong Chartered Governance Institute | Corporate Officer/Principal | ||
XIAMEN YAN PALACE BIRD'S NEST INDUSTRY CO., LTD. | Food: Major Diversified | Corporate Secretary | |
LSP Services Deutschland GmbH | Investment Managers | Private Equity Analyst | |
Madurai Kamaraj University | College/University | Graduate Degree | |
University of Utrecht | College/University | Doctorate Degree | |
Bavarian Nordic GmbH
![]() Bavarian Nordic GmbH BiotechnologyHealth Technology Part of Bavarian Nordic A/S, Bavarian Nordic GmbH engages in research and development in biotechnology for cancer and infectious diseases. The company is based in Martinsried, Germany. The German company was founded in 2014. Paul Chaplin has been the CEO of the company since 1999. | Biotechnology | Corporate Officer/Principal | |
Intelligencia, Inc.
![]() Intelligencia, Inc. Packaged SoftwareTechnology Services Intelligencia, Inc. develops artificial intelligence to de-risk clinical development. The firm offers data science solutions. The company was founded by Dimitrios Skaltsas and Vangelis Vergetis and is headquartered in New York, NY. | Packaged Software | Founder | |
CANBRIDGE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
EUCRATES BIOMEDICAL ACQUISITION CORP. | Financial Conglomerates | Founder | |
Hakluyt & Co. Ltd.
![]() Hakluyt & Co. Ltd. Miscellaneous Commercial ServicesCommercial Services Hakluyt & Co. Ltd. is a strategic advisory firm founded in 1997. The private company is based in London, UK and has subsidiaries in the United Kingdom and the United States. The British company supports corporations and investors in identifying opportunities and risks facing their businesses. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
McKinsey & Co., Inc.
![]() McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
WuXi Biologics Germany GmbH
![]() WuXi Biologics Germany GmbH BiotechnologyHealth Technology Part of Wuxi Biologics (Cayman), Inc., WuXi Biologics Germany GmbH is a company that engages in the development and manufacturing of biologics. The company is based in Leverkusen, Germany. The CEOs of the company are Zhisheng Chen, Jian Dong, Ming Zi Chen. | Biotechnology | Chief Executive Officer | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Doctorate Degree | |
CONNECT BIOPHARMA HOLDINGS LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Zion Pharma Ltd.
![]() Zion Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Zion Pharma Ltd. is a private, Chinese clinical stage biotech company founded in 2018. The company's research operations are located in mainland China and they have additional research operations elsewhere. The company is based in China and has subsidiaries in the country. The company is focused on developing novel, small molecule, anti-tumoral agents using an innovative drug discovery approach. Zion Pharma is capitalizing on its dmpk expertise to develop a pipeline of proprietary first-in-class/best-in-class compounds focused on therapeutic targets which drive tumor inhibition, including ataxia telangiectasia mutated (atm), kirsten rat sarcoma (kras g12d) and smarca2 (brm). | Miscellaneous Commercial Services | Director/Board Member | |
Abbisko Therapeutics Co., Ltd.
![]() Abbisko Therapeutics Co., Ltd. Pharmaceuticals: MajorHealth Technology Abbisko Therapeutics Co., Ltd. engages in the research and development of biomedicine and biotechnology. Its business includes technology transfer, technical advisory, and technical services. The company was founded on April 12, 2016 and is headquartered in Shanghai, China. | Pharmaceuticals: Major | Director/Board Member | |
JIANGSU YAHONG MEDITECH CO., LTD. | Pharmaceuticals: Major | Director/Board Member | |
Novigenix SA
![]() Novigenix SA Medical SpecialtiesHealth Technology Novigenix SA develops molecular diagnostics for cancer. The firm specializes in new generation liquid biopsy tests for early detection of cancer and precision medicine. The company was founded by Sahar Hosseinian in 2014 and is headquartered in Epalinges, Switzerland. | Medical Specialties | Director/Board Member | |
Amgen Rockville, Inc.
![]() Amgen Rockville, Inc. BiotechnologyHealth Technology Amgen Rockville, Inc. develops and commercializes antibody-based products. Its product development pipeline includes novel antibodies generated with its BiTE antibody platform, as well as conventional monoclonal antibodies. The company was founded in 1993 and is headquartered in Rockville, MD. | Biotechnology | Chief Administrative Officer | |
CellPly SRL
![]() CellPly SRL Medical SpecialtiesHealth Technology CellPly SRL develops and markets customized diagnostic tools for cancer treatment. The firm specializes in the design and marketing of solutions for defining the efficacy of immunotherapies and chemotherapies on cancer and immune cells. It offers a platform that analyzes ex-vivo samples and rare cells immediately after obtaining them from patients and preserving microenvironment conditions to readily provide information about tumor cell sensitivity to drugs and in-vivo status of single immune cells located close to tumor cells. The firm focuses on helping oncologists selecting the best treatment options, scientists studying cell response to therapy, and pharmaceutical companies increasing drug efficacy and rescuing drugs with limited efficacy through patient stratification. The company was founded by Massimo Bocchi and Roberto Guerrieri in 2013 and is headquartered in Bologna, Italy. | Medical Specialties | Consultant / Advisor |
Statistik
International
China | 19 |
Vereinigte Staaten | 15 |
Deutschland | 5 |
Schweiz | 4 |
Italien | 4 |
Sektoral
Health Technology | 20 |
Consumer Services | 11 |
Finance | 8 |
Technology Services | 5 |
Commercial Services | 4 |
Operativ
Director/Board Member | 81 |
Corporate Officer/Principal | 34 |
Founder | 19 |
Chief Executive Officer | 18 |
Graduate Degree | 18 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Min Fang | 19 |
Matthias Alder | 18 |
Kan Chen | 17 |
Kwan Wai Leung | 15 |
Jamie Gibson | 14 |
Jing Song Wang | 12 |
Garri Zmudze | 10 |
Miro Venturi | 10 |
Nirav Jhaveri | 10 |
Christine Huang | 8 |
Sergey Jakimov | 8 |
Natasha Drapeau | 8 |
Evangelos Vergetis | 7 |
Evgeny Izumchenko | 7 |
Naheed Kurji | 6 |
- Börse
- Insiders
- Aleksandrs Zhavoronkov
- Unternehmensverbindungen